RARE
Ultragenyx Pharmaceutical Inc.
$34.60
-$0.57(-1.62%)
49
Overall
40
Value
58
Tech
--
Quality
Market Cap
$3.35B
Volume
1.27M
52W Range
$25.81 - $53.47
Target Price
$85.85
EPS Estimates Overview
| Current Quarter | $-1.23 | Next Quarter | $-1.17 |
| Current Year | $-5.26 | Next Year | $-3.93 |
| QoQ Growth | +4.9% | YoY Growth | +25.3% |
| 3Y EPS CAGR | +2.1% | Target Price | $85.85 |
| Consensus | Buy | Upside | +148.1% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RARE | $34.60 | -1.6% | 1.27M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Ultragenyx Pharmaceutical Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW